Aktive Positionen von Sarah Plumridge
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FORTY SEVEN, INC. | Public Communications Contact | - | - |
Karriereverlauf von Sarah Plumridge
Statistik
International
| Vereinigte Staaten | 2 |
Operativ
| Public Communications Contact | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
- Börse
- Insiders
- Sarah Plumridge
- Erfahrung
